Yoneyama F - Search Results

1

Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).

Sasamori J, Aihara K, Yoneyama F, Sato I, Kogi K, Takeo S. Sasamori J, et al. Among authors: yoneyama f. J Cardiovasc Pharmacol. 2006 Apr;47(4):614-20. doi: 10.1097/01.fjc.0000211739.40336.c5. J Cardiovasc Pharmacol. 2006. PMID: 16680077

2

Yoneyama F, Aihara K, Kogi K, Satoh K, Taira N. Yoneyama F, et al. Tohoku J Exp Med. 1999 May;188(1):31-45. doi: 10.1620/tjem.188.31. Tohoku J Exp Med. 1999. PMID: 10494898 Free article.

3

Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury.

Aihara K, Hisa H, Sato T, Yoneyama F, Sasamori J, Yamaguchi F, Yoneyama S, Mizuno Y, Takahashi A, Nagai A, Kimura T, Kogi K, Satoh S. Aihara K, et al. Among authors: yoneyama s, yoneyama f. Eur J Pharmacol. 2000 Sep 15;404(1-2):221-9. doi: 10.1016/s0014-2999(00)00613-0. Eur J Pharmacol. 2000. PMID: 10980282

4

TY-12533, a novel Na(+)/H(+) exchange inhibitor, prevents myocardial stunning in dogs.

Aihara K, Hisa H, Sasamori J, Yoneyama F, Yamaguchi F, Satoh I, Satoh S. Aihara K, et al. Among authors: yoneyama f. Eur J Pharmacol. 2001 May 4;419(1):93-7. doi: 10.1016/s0014-2999(01)00952-9. Eur J Pharmacol. 2001. PMID: 11348635

5

Vasodepressor mechanisms of 2-(1-octynyl)-adenosine (YT-146), a selective adenosine A2 receptor agonist, involve the opening of glibenclamide-sensitive K+ channels.

Yoneyama F, Yamada H, Satoh K, Taira N. Yoneyama F, et al. Eur J Pharmacol. 1992 Mar 24;213(2):199-204. doi: 10.1016/0014-2999(92)90682-t. Eur J Pharmacol. 1992. PMID: 1521559

6

Cardiohemodynamic effect of FK409, a novel highly potent nitrovasodilator, in anesthetized dogs.

Yamada H, Yoneyama F, Satoh K, Taira N. Yamada H, et al. Among authors: yoneyama f. Eur J Pharmacol. 1991 Nov 19;205(1):81-3. doi: 10.1016/0014-2999(91)90773-j. Eur J Pharmacol. 1991. PMID: 1812001

7

A further study of the vasodilator and negative inotropic mechanisms of action of nicorandil and its congeners in the canine heart.

Satoh K, Orito K, Yoneyama F, Taira N. Satoh K, et al. Among authors: yoneyama f. Cardiovasc Drugs Ther. 1994 Apr;8(2):227-34. doi: 10.1007/BF00877331. Cardiovasc Drugs Ther. 1994. PMID: 7918135

8

Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.

Yoneyama F, Satoh K, Taira N. Yoneyama F, et al. Cardiovasc Drugs Ther. 1990 Aug;4(4):1119-26. doi: 10.1007/BF01856508. Cardiovasc Drugs Ther. 1990. PMID: 2150593

9

Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.

Yoneyama F, Yamada H, Satoh K, Taira N. Yoneyama F, et al. Cardiovasc Drugs Ther. 1990 Dec;4(6):1469-76. doi: 10.1007/BF02026494. Cardiovasc Drugs Ther. 1990. PMID: 2081139

10

Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.

Yamada H, Yoneyama F, Satoh K, Taira N. Yamada H, et al. Among authors: yoneyama f. Br J Pharmacol. 1990 Jul;100(3):413-6. doi: 10.1111/j.1476-5381.1990.tb15820.x. Br J Pharmacol. 1990. PMID: 2143956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters